Professor Kubo D. Sugahara Nagoya University.

Pancreatic cancer typically remains undetected for several years because the tumours can quickly respond to treatment by forming a pancreas tumour – – when the pancreas gland in the back of the neck cracks for instance female viagra. But the treatment itself isnt without risk: Around 10-15 % of unselected patients discover they have pancreatic cancer one year after being screened. As a result many have to undergo chemotherapy and some die from other cancersIn pancreatic cancer shows Sugahara the tumours form T-cell infiltrates that are responsible for triggering the immune system to kill the cancer cells. Even though the infiltrates can be crushed the cancer can form hard tumours in the pancreas liver gallbladder and other organs. And knowing the presence of the infiltrates can help determine the patients overall long-term risk of developing pancreatic cancer so that doctors can take the right steps to treat them – – whether it be surgery or a biopsy.

Scientists have developed a simple blood test to assess a patients risk for pancreatic cancer. The test developed by Professor Kubo D. Sugahara from Nagoya University Japan could be developed for screening of pancreatic cancer patients – – in preclinical experiments it successfully reduced the number of mice that died of the dangerous disease. The work published in the journal Proceedings of the National Academy of Sciences was conducted by Sugahara and team of National Institutes of Health -funded researchers at Doherty Institute of Genetics in collaboration with researchers at the University of Tohoku Royal Banbury Hospital and the University of Parma .